Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms

被引:58
|
作者
Kohtala, Samuel [1 ,2 ,3 ]
机构
[1] Univ Helsinki, Div Pharmacol & Pharmacotherapy, Drug Res Program, Lab Neurotherapeut,Fac Pharm, POB 56, Helsinki 00014, Finland
[2] Univ Helsinki, SleepWell Res Program, Fac Med, Helsinki, Finland
[3] Weill Cornell Med, Dept Psychiat, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA
关键词
Ketamine; Subanesthetic; Rapid-acting antidepressant; Depression; Dose; Anesthesia; TREATMENT-RESISTANT DEPRESSION; POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; D-ASPARTATE ANTAGONIST; PHANTOM LIMB PAIN; DOUBLE-BLIND; INTRAVENOUS KETAMINE; SUBANESTHETIC KETAMINE; ORAL ANTIDEPRESSANT; DOSE KETAMINE;
D O I
10.1007/s43440-021-00232-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Over the past 50 years, ketamine has solidified its position in both human and veterinary medicine as an important anesthetic with many uses. More recently, ketamine has been studied and used for several new indications, ranging from chronic pain to drug addiction and post-traumatic stress disorder. The discovery of the rapid-acting antidepressant effects of ketamine has resulted in a surge of interest towards understanding the precise mechanisms driving its effects. Indeed, ketamine may have had the largest impact for advancements in the research and treatment of psychiatric disorders in the past few decades. While intense research efforts have been aimed towards uncovering the molecular targets underlying ketamine's effects in treating depression, the underlying neurobiological mechanisms remain elusive. These efforts are made more difficult by ketamine's complex dose-dependent effects on molecular mechanisms, multiple pharmacologically active metabolites, and a mechanism of action associated with the facilitation of synaptic plasticity. This review aims to provide a brief overview of the different uses of ketamine, with an emphasis on examining ketamine's rapid antidepressant effects spanning molecular, cellular, and network levels. Another focus of the review is to offer a perspective on studies related to the different doses of ketamine used in antidepressant research. Finally, the review discusses some of the latest hypotheses concerning ketamine's action.
引用
收藏
页码:323 / 345
页数:23
相关论文
共 50 条
  • [31] Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms
    Krystal, John H.
    Kavalali, Ege T.
    Monteggia, Lisa M.
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 (01) : 41 - 50
  • [32] A Key Requirement for Synaptic Reelin Signaling in Rapid Antidepressant Effects of Ketamine
    Kim, Ji-Woon
    Herz, Joachim
    Kavalali, Ege
    Monteggia, Lisa
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (SUPPL 1) : 113 - 113
  • [33] Neurobiology of the Rapid-Acting Antidepressant Effects of Ketamine: Impact and Opportunities
    Shinohara, Ryota
    Aghajanian, George K.
    Abdallah, Chadi G.
    BIOLOGICAL PSYCHIATRY, 2021, 90 (02) : 85 - 95
  • [34] Rapid Acting Antidepressant Effects with Ketamine during Pandemic: A case series
    Sinha, Ankit
    Patra, Chinu
    Abhijita, Bandita
    Mishra, Shree
    Padhy, Susanta Kumar
    INDIAN JOURNAL OF PSYCHIATRY, 2023, 65 : S127 - S128
  • [35] Antidepressant actions of ketamine: from molecular mechanisms to clinical practice
    Monteggia, Lisa M.
    Zarate, Carlos, Jr.
    CURRENT OPINION IN NEUROBIOLOGY, 2015, 30 : 139 - 143
  • [36] Lateral Habenular Burst Firing as a Target of the Rapid Antidepressant Effects of Ketamine
    Cui, Yihui
    Hu, Shaohua
    Hu, Hailan
    TRENDS IN NEUROSCIENCES, 2019, 42 (03) : 179 - 191
  • [37] Towards an expanded neurocognitive account of ketamine's rapid antidepressant effects
    Dai, Yingliang
    Harrison, Ben J.
    Davey, Christopher G.
    Steward, Trevor
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 (02):
  • [38] Ketamine's dose related multiple mechanisms of actions: Dissociative anesthetic to rapid antidepressant
    Lavender, Eli
    Hirasawa-Fujita, Mika
    Domino, Edward F.
    BEHAVIOURAL BRAIN RESEARCH, 2020, 390
  • [39] Synaptic and neural mechanisms of agents with rapid acting antidepressant effects: Evidences for mGlu2/3 antagonists and ketamine
    Chaki, Shigeyuki
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 22 - 23
  • [40] The Impact of Intravenous Ketamine on Attentional Bias: Probing Mechanisms of Rapid-Acting Antidepressant Effects in Two Clinical Studies
    Woody, Mary L.
    Rohac, Rebecca
    Cooper, Iya
    Griffo, Angela
    McDonald, Nastasia
    Spotts, Crystal
    Fournier, Jay
    Jones, Neil
    Pecina, Marta
    Young, Kymberly
    Shivanekar, Sharvari
    Rengasamy, Manivel
    Grafton, Ben
    Price, Rebecca B.
    BIOLOGICAL PSYCHIATRY, 2025, 97 (08) : 835 - 842